| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/23/2003 | CN1432009A Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/23/2003 | CN1431907A Method of treating hepatitis delta viral infection |
| 07/23/2003 | CN1431904A Protease inhitors |
| 07/23/2003 | CN1431899A Pharmaceutical combination of bicalutamide and tamoxifen for providing anti-androgenic effect and anti-oestrogenic effect |
| 07/23/2003 | CN1431874A Use of polyphosphate as tooth erosion inhibitor in acidic compsns. |
| 07/23/2003 | CN1431215A Method for preparing glucoside in resveratrol of medicine to nourish liver and lowering fat |
| 07/23/2003 | CN1431203A 7-substitution-1-hero hydrogenated-2-ketone and ramification as well as its synthesizing method and usage |
| 07/23/2003 | CN1431200A Compound of phycocyania of blue-green algae, its preparing method and usage |
| 07/23/2003 | CN1431014A Extraction of ÔÇÿzuojinÔÇÖ total alkaloid and its application |
| 07/23/2003 | CN1431011A Oral medicine for curing hepatitis |
| 07/23/2003 | CN1431010A Medicine for treating discomforts in insteines and stomach |
| 07/23/2003 | CN1430999A Chinese herbal medicine combination for treating disease of disorder of bowels's function and its product |
| 07/23/2003 | CN1430998A Drip pills for curing aphtha and its preparing method |
| 07/23/2003 | CN1430996A Oral prepn. of big bupleurum root and its prodn. methods |
| 07/23/2003 | CN1430991A Medicine combination for treating chronic hepatitis B |
| 07/23/2003 | CN1430990A Detoxification tea of white bamboo |
| 07/23/2003 | CN1430982A Capsule of astragalus and honey as well as its preparing technique |
| 07/23/2003 | CN1430977A Capsule sheep extractive for protecting, strengthening health and preserving youth |
| 07/23/2003 | CN1430976A Medicine for treating liver disease |
| 07/23/2003 | CN1430975A Extractive of ocean star worm, its preparing method and application |
| 07/23/2003 | CN1430969A Combination of Chinese angelica polysaccharide and its preparing method |
| 07/23/2003 | CN1430956A Medicine for treating intestinal tract disease |
| 07/23/2003 | CN1430953A Tablet disintegzated in mouth rapidly for preventing and curing vomit and preparing method |
| 07/23/2003 | CN1115341C Substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases |
| 07/23/2003 | CN1115334C Pyridine derivative and pharmaceutical contg. same |
| 07/23/2003 | CN1115158C Health medicine for antisenescence |
| 07/23/2003 | CN1115157C Liver recovery decoction for treating liver disease and its prepn. method |
| 07/23/2003 | CN1115156C Antisenescence Chinese medicine |
| 07/23/2003 | CN1115151C Mixture of vasodilating agents and medical diluet or carrier in prepn. of medicine for treating liver disease |
| 07/23/2003 | CN1115146C Use of rifaximin in treatment of diarrhoea from cryptosporidiosis |
| 07/22/2003 | US6596923 Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 07/22/2003 | US6596900 Brain, nervous system, neurodegenerative, gastrointestinal, sleep, rheumatic, and psychological disorders; analgesics, antiepileptic agents |
| 07/22/2003 | US6596791 Polymer complexes of glucuronoglucanes |
| 07/22/2003 | US6596769 20-Hete antagonists and agonists |
| 07/22/2003 | US6596754 Preventives/remedies for multiple organ failure |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596745 Method for treating fibrotic diseases with azolium chroman compounds |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 07/22/2003 | US6596730 Phenyl urea and phenyl thiourea derivatives |
| 07/22/2003 | US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme |
| 07/22/2003 | US6596715 Protease inhibitors |
| 07/22/2003 | US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux |
| 07/22/2003 | US6596701 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/22/2003 | US6596687 Cell adhesion inhibitors |
| 07/22/2003 | US6596530 Lactobacillus for use in the generation of food product |
| 07/22/2003 | US6596313 Nutritional supplement and methods of using it |
| 07/22/2003 | US6596298 Pullulan and antimicrobially effective amounts of thymol, methyl salicylate, eucalyptol and menthol |
| 07/21/2003 | CA2416791A1 A receptor-ligand pairing for immune response |
| 07/21/2003 | CA2368656A1 Receptor-ligand pairing for anti-inflammatory response |
| 07/17/2003 | WO2003058203A2 Extended glucagon-like peptide-1 analogs |
| 07/17/2003 | WO2003057888A1 Cell-specific expression/replication vector |
| 07/17/2003 | WO2003057862A2 Transdifferentiation of pancreatic acinar cells |
| 07/17/2003 | WO2003057856A2 Dominant negative proteins and methods thereof |
| 07/17/2003 | WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057722A2 Cyclic tetrapeptide compound and use thereof |
| 07/17/2003 | WO2003057698A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/17/2003 | WO2003057696A1 Deazapurines and uses thereof |
| 07/17/2003 | WO2003057688A2 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | WO2003057671A1 Biaryl compound and use thereof |
| 07/17/2003 | WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057255A1 Drugs against obeisty and drugs against fatty liver |
| 07/17/2003 | WO2003057252A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | WO2003057245A1 Compositions for improving lipid metabolism |
| 07/17/2003 | WO2003057230A1 Composition used for combating cholesterol and improving digestion |
| 07/17/2003 | WO2003057220A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 07/17/2003 | WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 07/17/2003 | WO2003057211A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases. |
| 07/17/2003 | WO2003057205A2 Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs |
| 07/17/2003 | WO2003057196A1 Drug mixture with enhanced dissolution rate |
| 07/17/2003 | WO2003057166A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057133A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 07/17/2003 | WO2003039488A3 A method for treating inflammatory bowel disease |
| 07/17/2003 | WO2003030827A3 Compositions for and methods of treating and preventing sirs/sepsis |
| 07/17/2003 | WO2003020325A3 Methods for sterilizing preparations containing albumin |
| 07/17/2003 | WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 07/17/2003 | WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 07/17/2003 | WO2002055496A8 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/17/2003 | WO2002055495A8 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/17/2003 | WO2002046190A3 Sulfonamido ether substituted imidazoquinolines |
| 07/17/2003 | WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses |
| 07/17/2003 | WO2001094369A3 Heterocycle derivatives and methods of use for treating anthrax infection |
| 07/17/2003 | US20030134899 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect |
| 07/17/2003 | US20030134888 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 07/17/2003 | US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/17/2003 | US20030134862 Compounds |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134858 Treatment of inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease |
| 07/17/2003 | US20030134850 Hydrazinyl and nitrogen oxide pyrazoles |
| 07/17/2003 | US20030134849 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 07/17/2003 | US20030134848 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators |
| 07/17/2003 | US20030134847 New polycyclic azaindole compounds |
| 07/17/2003 | US20030134840 Novel compounds |